Advertisement
News
Advertisement

EU OKs Sanofi's takeover bid of Genzyme

Thu, 01/13/2011 - 6:36am
Mass High Tech: The Journal of New England Technology

The European Commission has approved French drug maker Sanofi-aventis’ proposed acquisition of Genzyme Corp. The EU regulators said that they do not have anti-trust concerns because plenty of viable competitors exist in the therapeutic areas that the two companies are focused on.

A statement from the European Commission read in part:

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading